Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

GlipiZIDE Extended-release Tablets

Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.

Terminated Dissolution failure American Health Packaging D-1276-2019
Class II · Moderate risk

TriMix MEDIUM

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Terminated Sterility / contamination Customceutical Compounding D-1262-2019
Class II · Moderate risk

Trimix HIGH

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Terminated Sterility / contamination Customceutical Compounding D-1261-2019
Class II · Moderate risk

Test PROCYP

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Terminated Sterility / contamination Customceutical Compounding D-1260-2019
Class II · Moderate risk

Lipoplex

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Terminated Sterility / contamination Customceutical Compounding D-1257-2019
Class II · Moderate risk

BPlex

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Terminated Sterility / contamination Customceutical Compounding D-1254-2019
Class II · Moderate risk

BPlex

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Terminated Sterility / contamination Customceutical Compounding D-1253-2019

Recalls by year